Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Five companies—Teva Pharmaceuticals USA, Lupin, Apotex, Anmeal Pharmaceuticals and Marksans Pharma—are voluntarily recalling in the US select lots of metformin extended-release formulations, a drug to treat Type 2 diabetes, due to evaluated levels...

AbbVie and Genmab, a biopharmaceutical company specializing in antibody therapeutics for treating cancer, have signed a broad collaboration agreement, worth up to $3.9 billion ($750 million up front with the potential to earn $3.15 billion in...

A roundup of news from Denmark (Lundbeck), Japan (Takeda), and the US (UCB). Denmark Lundbeck to Cut R&D Staff H. Lundbeck A/S, a Valby, Denmark biopharmaceutical company, is reorganizing its R&D-organization that may result in cut staff...

AstraZeneca has formed pacts with three organizations to supply 1.3 billion doses of an investigational COVID-19 vaccine candidate, which includes a $750-million deal for the supply of 300 million doses. In the first pact, AstraZeneca has formed a...

The US Food and Drug Administration (FDA) reports its laboratory testing has shown levels of the nitrosamine impurity, N-nitrosodimethylamine (NDMA), a potential carcinogen, above the agency’s acceptable intake limit in several lots of the...

The latest funding and donations by pharma companies supporting relief efforts against COVID-19 with news from AbbVie and Bayer. AbbVie Donates $5 M to 26 Nonprofits To Support COVID-19 Relief Efforts AbbVie has donated $5 million to 26...